Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AlphaMed Press is a specialized medical and scientific publishing company focused on oncology, stem cell research, and regenerative medicine. Established in 1983, the firm publishes several high-impact, peer-reviewed journals, most notably STEM CELLS, STEM CELLS Translational Medicine, and The Oncologist. The company serves the global scientific community by providing platforms for the dissemination of clinical trial data and translational research. AlphaMed Press also engages in educational initiatives and professional development for healthcare practitioners, aiming to accelerate the transition of laboratory discoveries into clinical practice. Its publications are essential resources for researchers and clinicians working at the intersection of basic science and patient care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AlphaMed Press.